Skepticism of PE-backed healthcare deals likely to continue under next FTC chair
BCLP's David Schwartz: 'The FTC has invested heavily in understanding and tracking private equity dealmaking in healthcare, and I do not see those investments being discarded just because of a change in administration.'
6 December 2024•4 mins read
